Financial Calendar

2026

February 13, 2026
Interim report (Q2), Oct-Dec 2025/2026
May 22, 2026
Interim report (Q3), Jan-Mar 2025/2026
August 28, 2026
Year-end report (Q4), Jul-Jun 2025/2026
October 30, 2026
Annual report, 2025/2026
November 13, 2026
Interim report (Q1), Jul-Sep 2026/2027
November 20, 2026
Annual General Meeting (AGM), 2025/2026

2025

February 13, 2025
Interim report (Q2), Oct-Dec 2024/2025
May 22, 2025
Interim report (Q3), Jan-Mar 2024/2025
August 28, 2025
Year-end report (Q4), Jul-Jun 2024/2025
October 31, 2025
Annual report, 2024/2025
November 14, 2025
Interim report (Q1), Jul-Sep 2025/2026
December 04, 2025
Annual General Meeting (AGM), 2024/2025

2024

February 22, 2024
Interim report (Q2), Oct-Dec 2023/2024
May 24, 2024
Interim report (Q3), Jan-Mar 2023/2024
August 28, 2024
Year-end report (Q4), Jul-Jun 2023/2024
October 31, 2024
Annual report, 2023/2024
November 15, 2024
Interim report (Q1), Jul-Sep 2024/2025
November 21, 2024
Annual General Meeting (AGM), 2023/2024

2023

November 17, 2023
Interim report (Q2), Oct-Dec 2023/2024
November 23, 2023
Annual report, 2022/2023
December 14, 2023
Annual General Meeting (AGM), 2022/2023
December 14, 2023
Extraordinary General Meeting (EGM), 2023
An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive
Pressreleases and Newsletters
© 2025
Hamlet BioPharma.